Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.22.32 (
bromelain
)
1,025
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Automated analyses were used to determine the effect of
retinol
on the activity of the following proteolytic enzymes: ficin (EC 3.4.4.12),
bromelain
(EC 3.4.4. 24), trypsin (EC 3.4.4.4.), chymotrypsin A (EC 3.4.4.5), papain (EC 3.4.4.10), clostridiopeptidase A (EC 3.4.4.19), pepsin (EC 3.4.4.1), cathepsin D (EC 3.4.4. 23) from rat-liver and rat-kidney lysosomes and the nonspecific proteolytic enzyme, pronase. Of these proteolytic enzymes only ficin,
bromelain
, and rat-kidney lysosomal cathepsin D were inhibited significantly by 1x10(-4) M
retinol
.Some nonproteolytic enzymes not inhibited by
retinol
were acid phosphatase (EC 3.1.3.2), beta-acetylglucosaminidase (EC 3.2.1.30), arylsulfatase (EC 3.1.6.1), and pyruvate kinase (EC 2.7.1.40). The inhibition of cathepsin D varied with the substrate used, being greater with hemoglobin than with ovalbumin or bovine serum albumin. Carotene and
retinol
inhibited ficin and cathepsin D to similar extents.
Retinol
inhibition of ficin was partially reversible. These studies of proteolytic enzyme inhibition by
retinol
serve as a simple model for studying
retinol
-protein interactions in vitro.
...
PMID:Retinol inhibition of some proteolytic enzymes. 1780 59